Shares of Health Care sector company Royalty Pharma moved 0.3% today, and are now trading at a price of $33.0. The large-cap stock's daily volume was 94,573 compared to its average volume of 2,059,088. The S&P 500 index returned a 0.0% performance.
9 analysts are following Royalty Pharma and have set target prices ranging from $42.0 to $60.0 per share. On average, they have given the company a rating of buy. At today's prices, RPRX is trading -35.96% away from its average analyst target price of $51.53 per share.
Over the last year, RPRX shares have gone down by -14.4%, which represents a difference of -29.0% when compared to the S&P 500. The stock's 52 week high is $44.66 per share and its 52 week low is $32.02. With average free cash flows of $1.97 Billion that have been growing at an average rate of 6.5% over the last 4 years, Royalty Pharma declining stock performance may not be reflective of the quality of its underlying business.
Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cashflow ($ k) | YoY Growth (%) |
---|---|---|---|---|
2022-12-31 | 2,143,980 | n/a | 2,143,980 | 6.27 |
2021-12-31 | 2,017,536 | n/a | 2,017,536 | -0.86 |
2020-12-31 | 2,034,629 | n/a | 2,035,000 | 22.06 |
2019-12-31 | 1,667,239 | n/a | 1,667,239 | n/a |